DK1817033T3 - Behandling af inflammatorisk tarmsygdom - Google Patents
Behandling af inflammatorisk tarmsygdomInfo
- Publication number
- DK1817033T3 DK1817033T3 DK05846549.3T DK05846549T DK1817033T3 DK 1817033 T3 DK1817033 T3 DK 1817033T3 DK 05846549 T DK05846549 T DK 05846549T DK 1817033 T3 DK1817033 T3 DK 1817033T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammatory bowel
- bowel disease
- treatment
- animal
- analog
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/999,451 US7326716B2 (en) | 2003-06-06 | 2004-11-29 | Treatment of inflammatory bowel disease |
| PCT/US2005/042467 WO2006058080A1 (en) | 2004-11-29 | 2005-11-22 | Treatment of inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1817033T3 true DK1817033T3 (da) | 2010-03-08 |
Family
ID=35903405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05846549.3T DK1817033T3 (da) | 2004-11-29 | 2005-11-22 | Behandling af inflammatorisk tarmsygdom |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7326716B2 (da) |
| EP (1) | EP1817033B1 (da) |
| AT (1) | ATE448785T1 (da) |
| AU (1) | AU2005309622A1 (da) |
| BR (1) | BRPI0518690A2 (da) |
| CA (1) | CA2589438C (da) |
| DE (1) | DE602005017815D1 (da) |
| DK (1) | DK1817033T3 (da) |
| ES (1) | ES2334374T3 (da) |
| WO (1) | WO2006058080A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7700627B2 (en) * | 2006-07-26 | 2010-04-20 | Allergan, Inc. | Therapeutic substituted lactams |
| CA2728161C (en) * | 2008-06-23 | 2017-06-06 | Nippon Shinyaku Co., Ltd. | Therapeutic agent for inflammatory bowel disease |
| EP2198879A1 (en) | 2008-12-11 | 2010-06-23 | Institut Curie | CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| EP2199273B1 (en) | 2008-12-18 | 2018-02-21 | Agfa Nv | Polymerizable photoinitiators and radiation curable compositions |
| WO2010133381A1 (en) | 2009-05-18 | 2010-11-25 | Agfa Graphics Nv | Polymerizable polymeric photoinitiators and radiation curable compositions |
| US20120190637A1 (en) | 2009-10-14 | 2012-07-26 | Gemmus Pharma, Inc. | Combination therapy treatment for viral infections |
| ES2565984T3 (es) | 2010-10-20 | 2016-04-08 | Agfa Graphics N.V. | Fotoiniciadores polimerizables para composiciones curables por LED |
| US20140142042A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| MX2016001714A (es) | 2013-08-09 | 2016-10-03 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
| EP2868650B1 (en) | 2013-10-30 | 2018-08-08 | Agfa Nv | Synthesis of acetal compounds using zwitterionic catalysts |
| US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028624A (en) * | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
| US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
| US5034413A (en) * | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
| CA2021316C (en) * | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
| SE520947C2 (sv) * | 2002-01-18 | 2003-09-16 | Aneo Ab | Ventilarrangemang för blandning av två medier |
| WO2004029581A2 (en) * | 2002-09-26 | 2004-04-08 | The Children's Hospital Of Philadelphia | Method of determining surface binding capacity |
| US7053085B2 (en) | 2003-03-26 | 2006-05-30 | Merck & Co. Inc. | EP4 receptor agonist, compositions and methods thereof |
| JP2006515015A (ja) * | 2003-01-10 | 2006-05-18 | エフ．ホフマン−ラ ロシュ アーゲー | プロスタグランジンアゴニストとしての２−ピペリドン誘導体 |
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US6977260B2 (en) * | 2004-01-22 | 2005-12-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US6747037B1 (en) * | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| DE10341727A1 (de) * | 2003-09-10 | 2005-04-28 | Starck H C Gmbh | Reinigung von Ammoniummetallat-Lösungen |
| EP1761495B1 (en) | 2004-06-04 | 2012-03-21 | Allergan, Inc. | Piperidinyl prostaglandin analogs as ocular hypotensive agents |
-
2004
- 2004-11-29 US US10/999,451 patent/US7326716B2/en active Active
-
2005
- 2005-11-22 AT AT05846549T patent/ATE448785T1/de not_active IP Right Cessation
- 2005-11-22 EP EP05846549A patent/EP1817033B1/en not_active Not-in-force
- 2005-11-22 BR BRPI0518690-0A patent/BRPI0518690A2/pt not_active IP Right Cessation
- 2005-11-22 DK DK05846549.3T patent/DK1817033T3/da active
- 2005-11-22 ES ES05846549T patent/ES2334374T3/es active Active
- 2005-11-22 CA CA2589438A patent/CA2589438C/en not_active Expired - Fee Related
- 2005-11-22 DE DE602005017815T patent/DE602005017815D1/de active Active
- 2005-11-22 WO PCT/US2005/042467 patent/WO2006058080A1/en active Application Filing
- 2005-11-22 AU AU2005309622A patent/AU2005309622A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006058080A1 (en) | 2006-06-01 |
| CA2589438C (en) | 2014-07-22 |
| ATE448785T1 (de) | 2009-12-15 |
| US7326716B2 (en) | 2008-02-05 |
| US20050171062A1 (en) | 2005-08-04 |
| EP1817033A1 (en) | 2007-08-15 |
| BRPI0518690A2 (pt) | 2008-12-02 |
| CA2589438A1 (en) | 2006-06-01 |
| EP1817033B1 (en) | 2009-11-18 |
| AU2005309622A1 (en) | 2006-06-01 |
| ES2334374T3 (es) | 2010-03-09 |
| DE602005017815D1 (de) | 2009-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1817033T3 (da) | Behandling af inflammatorisk tarmsygdom | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| NO20084502L (no) | Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer | |
| ECSP066684A (es) | Nitrooxiderivados de prostaglandinas | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| PA8640701A1 (es) | Indazoles utiles para tratamiento de enfermedades cardiovascular | |
| ATE478864T1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| EA200900178A1 (ru) | Конденсированные гетероциклические производные и их применение | |
| EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
| TW200612911A (en) | Compounds for the treatment of inflammatory disorders | |
| EA200601239A1 (ru) | Замещённые хинолиновые соединения | |
| EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| DK2023918T3 (da) | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser | |
| EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA200900779A1 (ru) | Производные дигидропиридина, полезные как ингибиторы протеинкиназы | |
| EA200601895A1 (ru) | 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов | |
| CR9721A (es) | Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| DE60219614D1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
| EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
| DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| EA200970436A1 (ru) | Соединения карбамата для лечения депрессии | |
| EA200601871A1 (ru) | Способы лечения аутоиммунных и воспалительных заболеваний |